GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

Clinical trial NCT07749976 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07749976
Sponsor: Vitruviae
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Diffuse Large B Cell Lymphoma (DLBCL)High Risk Myelodysplastic Syndrome Solid Tumor Malignancies Pediatric Acute Myeloid Leukemia

Start date: 2027-01-01
Primary completion: 2028-01-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.